We found modulations in core cellular processes involved in tumor progression, such as anabolism (ElF2 and mTOR signaling) and metabolic control (Sirtuin signaling), in GBM cells exposed to MSC or MSCMel (Figure 4E-F). The gene discussed is MTOR; the disease is glioblastoma.